标题
Interference between copper transport systems and platinum drugs
作者
关键词
Cisplatin, Cancer, Copper transporters, Copper homeostasis, Platinum trafficking, Cisplatin resistance, Sensitization therapy, Pt-interference with copper metabolism, CTR1, ATP7A, ATP7B, ATOX1
出版物
SEMINARS IN CANCER BIOLOGY
Volume 76, Issue -, Pages 173-188
出版商
Elsevier BV
发表日期
2021-05-29
DOI
10.1016/j.semcancer.2021.05.023
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Nuclear translocation of Atox1 potentiates activin A-induced cell migration and colony formation in colon cancer
- (2020) Arundhati Jana et al. PLoS One
- Single-cell tracking demonstrates copper chaperone Atox1 to be required for breast cancer cell migration
- (2020) Stéphanie Blockhuys et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Synthetic Lethality Screening Identifies FDA-Approved Drugs that Overcome ATP7B-Mediated Tolerance of Tumor Cells to Cisplatin
- (2020) Marta Mariniello et al. Cancers
- Role of Nucleotide Excision Repair in Cisplatin Resistance
- (2020) Mingrui Duan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Multifaceted Roles of Copper in Cancer: A Trace Metal Element with Dysregulated Metabolism, but Also a Target or a Bullet for Therapy
- (2020) Pierre Lelièvre et al. Cancers
- Effects of Copper Chelation on BRAFV600E Positive Colon Carcinoma Cells
- (2019) Silvia Baldari et al. Cancers
- Mechanistic and Structural Basis for Inhibition of Copper Trafficking by Platinum Anticancer Drugs
- (2019) Alessia Lasorsa et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Activity and Trafficking of Copper-Transporting ATPases in Tumor Development and Defense against Platinum-Based Drugs
- (2019) Raffaella Petruzzelli et al. Cells
- Differential Reactivity of Metal Binding Domains of Copper ATPases towards Cisplatin and Colocalization of Copper and Platinum
- (2018) Tiantian Fang et al. CHEMISTRY-A EUROPEAN JOURNAL
- Platinum drugs, copper transporters and copper chelators
- (2018) Fabio Arnesano et al. COORDINATION CHEMISTRY REVIEWS
- Tetrathiomolybdate inhibits the reaction of cisplatin with human copper chaperone Atox1
- (2018) Yao Tian et al. Metallomics
- Repair shielding of platinum-DNA lesions in testicular germ cell tumors by high-mobility group box protein 4 imparts cisplatin hypersensitivity
- (2017) Samuel G. Awuah et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Platinum-based drugs: past, present and future
- (2016) Shahana Dilruba et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
- (2016) Timothy C. Johnstone et al. CHEMICAL REVIEWS
- Cisplatin binding to proteins: A structural perspective
- (2016) Luigi Messori et al. COORDINATION CHEMISTRY REVIEWS
- Cisplatin resistance and opportunities for precision medicine
- (2016) Lauren Amable PHARMACOLOGICAL RESEARCH
- Ammonium tetrathiomolybdate treatment targets the copper transporter ATP7A and enhances sensitivity of breast cancer to cisplatin
- (2016) Cristine L. Chisholm et al. Oncotarget
- Mechanistic basis of a combination d-penicillamine and platinum drugs synergistically inhibits tumor growth in oxaliplatin-resistant human cervical cancer cells in vitro and in vivo
- (2015) Szu-Jung Chen et al. BIOCHEMICAL PHARMACOLOGY
- Pharmacological activity of metal binding agents that alter copper bioavailability
- (2015) Marian E. Helsel et al. DALTON TRANSACTIONS
- Identification of New Potential Interaction Partners for Human Cytoplasmic Copper Chaperone Atox1: Roles in Gene Regulation?
- (2015) Helena Öhrvik et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The role of Ctr1 and Ctr2 in mammalian copper homeostasis and platinum-based chemotherapy
- (2015) Helena Öhrvik et al. JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
- Curcumin and cancer: barriers to obtaining a health claim
- (2015) J. G. Devassy et al. NUTRITION REVIEWS
- Human Copper Chaperone Atox1 Translocates to the Nucleus but does not Bind DNA In Vitro
- (2015) Dana Kahra et al. PROTEIN AND PEPTIDE LETTERS
- HMGB1 bound to cisplatin–DNA adducts undergoes extensive acetylation and phosphorylation in vivo
- (2015) Yafeng He et al. Chemical Science
- Copper Transport Protein Antioxidant-1 Promotes Inflammatory Neovascularization via Chaperone and Transcription Factor Function
- (2015) Gin-Fu Chen et al. Scientific Reports
- Biochemical characterization of P-type copper ATPases
- (2014) Giuseppe Inesi et al. BIOCHEMICAL JOURNAL
- Structural Biology of Cisplatin Complexes with Cellular Targets: The Adduct with Human Copper Chaperone Atox1 in Aqueous Solution
- (2014) Vania Calandrini et al. CHEMISTRY-A EUROPEAN JOURNAL
- Platination of the copper transporter ATP7A involved in anticancer drug resistance
- (2014) Vania Calandrini et al. DALTON TRANSACTIONS
- Cisplatin handover between copper transporters: the effect of reducing agents
- (2014) Angela Galliani et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Increasing Intracellular Bioavailable Copper Selectively Targets Prostate Cancer Cells
- (2013) Michael A. Cater et al. ACS Chemical Biology
- Translocation of Platinum Anticancer Drugs by Human Copper ATPases ATP7A and ATP7B
- (2013) Francesco Tadini-Buoninsegni et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Copper chaperone Atox1 interacts with the metal-binding domain of Wilson's disease protein in cisplatin detoxification
- (2013) Nataliya V. Dolgova et al. BIOCHEMICAL JOURNAL
- Copper binding promotes the interaction of cisplatin with human copper chaperone Atox1
- (2013) Zhaoyong Xi et al. CHEMICAL COMMUNICATIONS
- An Updated View of Cisplatin Transport
- (2013) Fabio Arnesano et al. EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
- Determinants for Simultaneous Binding of Copper and Platinum to Human Chaperone Atox1: Hitchhiking not Hijacking
- (2013) Maria E. Palm-Espling et al. PLoS One
- Bioavailable copper modulates oxidative phosphorylation and growth of tumors
- (2013) S. Ishida et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ctr2 regulates biogenesis of a cleaved form of mammalian Ctr1 metal transporter lacking the copper- and cisplatin-binding ecto-domain
- (2013) H. Ohrvik et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Better Platinum-Based Anticancer Drug Yet to Come?
- (2012) Ulrike Olszewski et al. Anti-Cancer Agents in Medicinal Chemistry
- Copper influx transporter 1 is required for FGF, PDGF and EGF-induced MAPK signaling
- (2012) Cheng-Yu Tsai et al. BIOCHEMICAL PHARMACOLOGY
- Reaction of platinum anticancer drugs and drug derivatives with a copper transporting protein, Atox1
- (2012) Maria E. Palm-Espling et al. BIOCHEMICAL PHARMACOLOGY
- Binding Interaction of HMGB4 with Cisplatin-Modified DNA
- (2012) Semi Park et al. BIOCHEMISTRY
- Structural Determinants of Cisplatin and Transplatin Binding to the Met-Rich Motif of Ctr1: A Computational Spectroscopy Approach
- (2012) Trung Hai Nguyen et al. Journal of Chemical Theory and Computation
- Relevance of copper transporter 1 for cisplatin resistance in human ovarian carcinoma cells
- (2012) Ganna V. Kalayda et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- The CXXC motifs in the metal binding domains are required for ATP7B to mediate resistance to cisplatin
- (2012) Roohangiz Safaei et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Copper-transporting P-type adenosine triphosphatase (ATP7A) is associated with platinum-resistance in non-small cell lung cancer (NSCLC)
- (2012) Zhuang-hua Li et al. Journal of Translational Medicine
- Prediction of copper transport protein 1 (CTR1) genotype on severe cisplatin induced toxicity in non-small cell lung cancer (NSCLC) patients
- (2012) Xiaojing Xu et al. LUNG CANCER
- A Novel Role for Copper in Ras/Mitogen-Activated Protein Kinase Signaling
- (2012) M. L. Turski et al. MOLECULAR AND CELLULAR BIOLOGY
- Distorted copper homeostasis with decreased sensitivity to cisplatin upon chaperone Atox1 deletion in Drosophila
- (2011) Haiqing Hua et al. BIOMETALS
- Prognostic value of the copper transporters, CTR1 and CTR2, in patients with ovarian carcinoma receiving platinum-based chemotherapy
- (2011) Yoo-Young Lee et al. GYNECOLOGIC ONCOLOGY
- Probing the Interaction of Cisplatin with the Human Copper Chaperone Atox1 by Solution and In-Cell NMR Spectroscopy
- (2011) Fabio Arnesano et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Cisplatin binds human copper chaperone Atox1 and promotes unfolding in vitro
- (2011) M. E. Palm et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
- (2011) Ana-Maria Florea et al. Cancers
- Copper Metallochaperones
- (2010) Nigel J. Robinson et al. Annual Review of Biochemistry
- Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator
- (2010) Seiko Ishida et al. CANCER CELL
- Regulation of Copper Transporter 2 Expression by Copper and Cisplatin in Human Ovarian Carcinoma Cells
- (2010) B. G. Blair et al. MOLECULAR PHARMACOLOGY
- The soluble metal-binding domain of the copper transporter ATP7B binds and detoxifies cisplatin
- (2009) Nataliya V. Dolgova et al. BIOCHEMICAL JOURNAL
- Therapeutic Targeting of ATP7B in Ovarian Carcinoma
- (2009) L. S. Mangala et al. CLINICAL CANCER RESEARCH
- Copper Transporter 2 Regulates the Cellular Accumulation and Cytotoxicity of Cisplatin and Carboplatin
- (2009) B. G. Blair et al. CLINICAL CANCER RESEARCH
- Metal Complexes, their Cellular Targets and Potential for Cancer Therapy
- (2009) Di Chen et al. CURRENT PHARMACEUTICAL DESIGN
- Cisplatin Overdose
- (2009) Roger Y. Tsang et al. DRUG SAFETY
- Human copper transporters: mechanism, role in human diseases and therapeutic potential
- (2009) Arnab Gupta et al. Future Medicinal Chemistry
- New-generation platinum agents for solid tumors
- (2009) Neel Shah et al. Future Oncology
- Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1
- (2009) Zhengyi Wu et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Crystal Structures of Cisplatin Bound to a Human Copper Chaperone
- (2009) Amie K. Boal et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Coordination of platinum therapeutic agents to met-rich motifs of human copper transport protein1
- (2009) Sarah E. Crider et al. Metallomics
- Tetrathiomolybdate Inhibits Copper Trafficking Proteins Through Metal Cluster Formation
- (2009) H. M. Alvarez et al. SCIENCE
- Treatment of Wilson's disease with tetrathiomolybdate: V. control of free copper by tetrathiomolybdate and a comparison with trientine
- (2009) George J. Brewer et al. Translational Research
- The complexities of antiretroviral drug–drug interactions: role of ABC and SLC transporters
- (2009) Olena Kis et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells
- (2008) Ganna V Kalayda et al. BMC CANCER
- Novel mechanism for regulation of extracellular SOD transcription and activity by copper: Role of antioxidant-1
- (2008) S ITOH et al. FREE RADICAL BIOLOGY AND MEDICINE
- Novel Role of Antioxidant-1 (Atox1) as a Copper-dependent Transcription Factor Involved in Cell Proliferation
- (2008) Shinichi Itoh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Interaction of cisplatin and analogues with a Met-rich protein site
- (2008) Chak Ming Sze et al. JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY
- Effects of the loss of Atox1 on the cellular pharmacology of cisplatin
- (2008) Roohangiz Safaei et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- The Role of Cellular Accumulation in Determining Sensitivity to Platinum-Based Chemotherapy
- (2007) Matthew D. Hall et al. Annual Review of Pharmacology and Toxicology
- Unique Properties of DNA Interstrand Cross-Links of Antitumor Oxaliplatin and the Effect of Chirality of the Carrier Ligand
- (2007) Jana Kasparkova et al. CHEMISTRY-A EUROPEAN JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started